Agree. I suggest a CR likely towards end of next year if they don't secure substantial increase in US sales or guaranteed revenues from the current IP deal.
This is jump and slump trade given the SP was at .029.
Likely see it settle on CR price more than anything and then stagnate until the CLIA study news is released. Might push it back to mid .04c but until quarterly next year (if substantial uptake of product is realised) and then go for a run for people.
A lot of ifs still.
Agree. I suggest a CR likely towards end of next year if they...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $20.95M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.7¢ | $51.65K | 1.829M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 308289 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 518837 | 4 |
View Market Depth
| Last trade - 15.50pm 16/06/2025 (20 minute delay) ? |
| LDX (ASX) Chart |